ISU302

DRUG3 trials

Sponsors

ISU Abxis Co., Ltd.

Conditions

Gaucher DiseaseGaucher Disease, Type 1

Phase 1

A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers

CompletedNCT01881633

ISU Abxis Co., Ltd.Gaucher Disease

Start: 2010-10-31End: 2010-11-30Updated: 2013-06-19

Phase 3

The Safety and Efficacy Study of ISU302 in Patient With Type I Gaucher Disease

WithdrawnNCT01161914

ISU Abxis Co., Ltd.Gaucher Disease

Start: 2011-01-31Updated: 2016-08-23

Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease

CompletedNCT02770625

ISU Abxis Co., Ltd.Gaucher Disease, Type 1

Start: 2011-09-30End: 2014-08-31Updated: 2017-07-12